Live Quote · OTCBIOGFHealthcare · Medical - Diagnostics & Research

Biocartis Group N.V.

$0.66▼ 85.33%($-3.84)

TickerSpark Score

65/100

▌ Solid

100

Valuation

50

Profitability

85

Growth

60

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOGF research report →

52-Week Range50% of range

Low

$0.66

Current

$0.66

High

$0.66

Company Overviewwww.biocartis.com

About the company

Biocartis Group N. V. is a molecular diagnostics firm dedicated to advancing clinical practice through innovative diagnostic solutions.

CEO: Roger Moody
IPO: 2021
Employees: 526
HQ: Mechelen, BE

Price Chart

-85.33% · this period

Valuation

Market Cap: $65.41M
P/E: -0.27
P/S: 0.47
P/B: -0.58
EV/EBITDA: -2.81
Div Yield: 0.00%

Profitability

Gross Margin: 48.16%
Op Margin: -81.85%
Net Margin: -113.74%
ROE: 203.74%
ROIC: -50.72%

Growth & Income

Revenue: $57.48M · 19.08%
Net Income: $-65,381,000 · 8.52%
EPS: $-1.08 · 12.90%
Op Income: $-47,047,000
FCF YoY: 32.65%

Performance & Tape

52W High: $0.66
52W Low: $0.66
50D MA: $0.66
200D MA: $0.66
Beta: 1.39
Avg Volume: 0

Get TickerSpark's AI analysis on BIOGF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · BIOGF